title: Hyperplasia from GLP-1 drugs is "not a surprise," say researchers.
authors.forename: Deborah
authors.initials: D
authors.lastname: Cohen
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D052216:Glucagon-Like Peptide 1 / Q000009:adverse effects*; D006801:Humans; D006965:Hyperplasia / Q000139:chemically induced; D054795:Incretins / Q000009:adverse effects*; D008679:Metaplasia / Q000139:chemically induced; D010179:Pancreas / Q000473:pathology*; D010190:Pancreatic Neoplasms / Q000139:chemically induced*; D010195:Pancreatitis / Q000139:chemically induced*
chemical_list: D054795:Incretins; D052216:Glucagon-Like Peptide 1